These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

140 related items for PubMed ID: 27559

  • 1. Characterization of the effects of endotoxin on macrophage tumor cell killing.
    Weinberg JB, Chapman HA, Hibbs JB.
    J Immunol; 1978 Jul; 121(1):72-80. PubMed ID: 27559
    [No Abstract] [Full Text] [Related]

  • 2. Tumor cytotoxicity of rat alveolar macrophages activated in vitro by endotoxin.
    Sone S, Fidler IJ.
    J Reticuloendothel Soc; 1980 Mar; 27(3):269-79. PubMed ID: 7365733
    [No Abstract] [Full Text] [Related]

  • 3. Tumor-cytotoxic activity of resident rat macrophages.
    Johnson WJ, Balish E.
    J Reticuloendothel Soc; 1981 May; 29(5):369-79. PubMed ID: 7241409
    [No Abstract] [Full Text] [Related]

  • 4. In vivo modulation of macrophage tumoricidal activity: enhanced tumor cell killing by peritoneal macrophages from mice given injections of sodium periodate.
    Weinberg JB.
    J Natl Cancer Inst; 1981 Mar; 66(3):529-33. PubMed ID: 6259399
    [Abstract] [Full Text] [Related]

  • 5. Macrophage tumor necrosis factor-alpha release is induced by contact with some tumors.
    Hasday JD, Shah EM, Lieberman AP.
    J Immunol; 1990 Jul 01; 145(1):371-9. PubMed ID: 2358679
    [Abstract] [Full Text] [Related]

  • 6. Macrophage activation for tumor cytotoxicity: control of macrophage tumoricidal capacity by the LPS gene.
    Ruco LP, Meltzer MS, Rosenstreich DL.
    J Immunol; 1978 Aug 01; 121(2):543-8. PubMed ID: 681749
    [No Abstract] [Full Text] [Related]

  • 7. Identification and characterization of monoclonal antibodies specific for macrophages at intermediate stages in the tumoricidal activation pathway.
    Paulnock DM, Lambert LE.
    J Immunol; 1990 Jan 15; 144(2):765-73. PubMed ID: 2104906
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Characterization of tumor binding by the IC-21 macrophage cell line.
    Crawford EK, Latham PS, Shah EM, Hasday JD.
    Cancer Res; 1990 Aug 01; 50(15):4578-83. PubMed ID: 2164442
    [Abstract] [Full Text] [Related]

  • 16. Effects of tumor-promoting agents on cells of the murine immune system: inhibition of antibody synthesis and of macrophage-mediated tumor cell cytotoxicity.
    Baxter CS, Fish LA, Ferguson TA, Michael JG, Bash JA.
    Carcinog Compr Surv; 1982 Aug 01; 7():637-42. PubMed ID: 6978182
    [No Abstract] [Full Text] [Related]

  • 17. The activation of tumoricidal properties in macrophages of endotoxin responder and nonresponder mice by liposome-encapsulated immunomodulators.
    Fogler WE, Talmadge JE, Fidler IJ.
    J Reticuloendothel Soc; 1983 Mar 01; 33(3):165-74. PubMed ID: 6834360
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.